Michael R. Harrison, MD Associate Professor of Medicine
Duke Cancer Institute discusses Active Surveillance for Favorable Risk mRCC at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Active Surveillance for Favorable Risk mRCC
By Editor